Arvind Remedies shines on commencing commercial operation of new unit in Tamil Nadu

26 Feb 2014 Evaluate

Arvind Remedies is currently trading at Rs. 43.20, up by 0.40 points or 0.93% from its previous closing of Rs. 42.80 on the BSE.

The scrip opened at Rs. 43.30 and has touched a high and low of Rs. 43.70 and Rs. 43.15 respectively. So far 6276 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 59.95 on 08-Nov-2013 and a 52 week low of Rs. 24.85 on 01-Mar-2013.

Last one week high and low of the scrip stood at Rs. 44.90 and Rs. 42.50 respectively. The current market cap of the company is Rs. 296.69 crore.

The promoters holding in the company stood at 36.31% while Institutions and Non-Institutions held 0.06% and 63.63% respectively.

Arvind Remedies has commenced commercial operation of the new unit at Kakkalur, Tiruvellore in Tamil Nadu. Earlier, the company had signed a Memorandum of Understanding (MoU) with four institutions to manufacture and market medicines from botanical source, which are useful for the treatment and management of Neuro-degeneration disorder (like alzheimer, parkinson) and Neuropsychiatry disorders (like depression). The four educational institutions with whom the company had inked MoU are Banaras Hindu University, Adesh University, SRM University and Genome Foundation.

Arvind Remedies is engaged in the manufacturing of pharmaceutical formulations such as tablets, capsules (including soft gels), ointments and liquids. ARL markets its products in the institutional (primarily government organizations) and ethical segments, with institutional segment contributing to 70% of the total revenues.

Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×